[SCHEDULE 13G/A] Creative Medical Technology Holdings, Inc. SEC Filing
Armistice Capital, LLC and Steven Boyd report shared beneficial ownership of 135,531 shares of Creative Medical Technology Holdings, Inc. common stock, representing 4.99% of the class. Armistice Capital, as investment manager to Armistice Capital Master Fund Ltd., exercises voting and investment power over the shares held by the Master Fund, and Mr. Boyd, as managing member, is reported with the same shared voting and dispositive power. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The Master Fund is identified as the direct holder and retains the right to receive dividends or sale proceeds.
Armistice Capital, LLC e Steven Boyd comunicano la titolarit脿 condivisa di 135.531 azioni ordinarie di Creative Medical Technology Holdings, Inc., pari al 4,99% della classe. Armistice Capital, in qualit脿 di gestore degli investimenti per Armistice Capital Master Fund Ltd., esercita il diritto di voto e il potere d'investimento sulle azioni detenute dal Master Fund; il sig. Boyd, in qualit脿 di membro amministratore, viene segnalato con gli stessi poteri congiunti di voto e disposizione. La comunicazione precisa che le azioni sono state acquisiste e sono detenute nell'ordinaria attivit脿 d'impresa e non con l'intento di modificare o influenzare il controllo dell'emittente. Il Master Fund 猫 indicato come detentore diretto e mantiene il diritto a ricevere dividendi o proventi di vendita.
Armistice Capital, LLC y Steven Boyd informan de la propiedad conjunta de 135.531 acciones ordinarias de Creative Medical Technology Holdings, Inc., que representan el 4,99% de la clase. Armistice Capital, como gestor de inversiones de Armistice Capital Master Fund Ltd., ejerce el derecho de voto y el poder de inversi贸n sobre las acciones en poder del Master Fund; el Sr. Boyd, como miembro gerente, figura con los mismos poderes compartidos de voto y disposici贸n. La presentaci贸n indica que las acciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no con la intenci贸n de cambiar o influir en el control del emisor. El Master Fund se identifica como el titular directo y conserva el derecho a recibir dividendos o los ingresos de una venta.
Armistice Capital, LLC鞕� Steven Boyd電� Creative Medical Technology Holdings, Inc. 氤错喌欤� 135,531欤茧ゼ 瓿惦彊鞙茧 鞁れ鞝侅溂搿� 靻岇湢頃橁碃 鞛堨溂氅� 鞚措姅 韥措灅鞀れ潣 4.99%鞐� 頃措嫻頃滊嫟瓿� 氤搓碃頃╇媹雼�. Armistice Capital鞚� Armistice Capital Master Fund Ltd.鞚� 韴瀽甏�毽瀽搿滌劀 毵堨姢韯� 韼�霌滉皜 氤挫湢頃� 欤检嫕鞐� 雽�頃� 鞚橁舶甓岅臣 韴瀽甓岇潉 頄夓偓頃橂┌, Boyd 鞌姅 甏�毽� 甑劚鞗愳溂搿滌劀 霃欖澕頃� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳甓岇潉 氤挫湢頃� 瓴冹溂搿� 氤搓碃霅╇媹雼�. 鞝滌稖靹滊電� 頃措嫻 欤检嫕鞚� 鞓侅梾鞚� 韱奠儊鞝� 瓿检爼鞐愳劀 旆摑路氤挫湢霅橃棃鞙茧┌ 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳範 氇╈爜鞙茧 氤挫湢霅� 瓴冹澊 鞎勲嫎鞚� 氇呾嫓頃╇媹雼�. 毵堨姢韯� 韼�霌滊姅 歆侅爲 氤挫湢鞛愲 頇曥澑霅橂┌ 氚半嫻旮� 霕愲姅 毵り皝 雽�旮堨潉 靾橂牴頃� 甓岆Μ毳� 鞙犾頃╇媹雼�.
Armistice Capital, LLC et Steven Boyd d茅clarent la propri茅t茅 b茅n茅ficiaire conjointe de 135听531 actions ordinaires de Creative Medical Technology Holdings, Inc., repr茅sentant 4,99聽% de la cat茅gorie. Armistice Capital, en tant que gestionnaire d'investissement pour Armistice Capital Master Fund Ltd., exerce les droits de vote et le pouvoir d'investissement sur les actions d茅tenues par le Master Fund ; M. Boyd, en tant que membre gestionnaire, est indiqu茅 comme d茅tenant les m锚mes pouvoirs conjoints de vote et de disposition. Le d茅p么t pr茅cise que les actions ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Le Master Fund est identifi茅 comme le d茅tenteur direct et conserve le droit de percevoir dividendes ou produits de cession.
Armistice Capital, LLC und Steven Boyd melden die gemeinsame wirtschaftliche Eigent眉merschaft an 135.531 Stammaktien der Creative Medical Technology Holdings, Inc., was 4,99 % der Klasse entspricht. Armistice Capital 眉bt als Investmentmanager des Armistice Capital Master Fund Ltd. Stimm- und Anlagebefugnisse 眉ber die vom Master Fund gehaltenen Aktien aus; Herr Boyd wird als gesch盲ftsf眉hrendes Mitglied mit denselben gemeinsamen Stimm- und Verf眉gungsbefugnissen angegeben. Die Meldung erkl盲rt, dass die Aktien im gew枚hnlichen Gesch盲ftsverlauf erworben und gehalten werden und nicht zum Zweck der 脛nderung oder Beeinflussung der Kontrolle des Emittenten dienen. Der Master Fund wird als direkter Inhaber genannt und beh盲lt das Recht, Dividenden oder Verkaufserl枚se zu erhalten.
- Transparent disclosure of a 4.99% position by Armistice Capital and Steven Boyd, clarifying ownership and voting arrangements
- Joint filing and certification confirm holdings are ordinary-course investments and not intended to change control
- No sole voting or dispositive power reported; all voting and disposition are shared rather than controlled solely by the reporting persons
Insights
TL;DR: A reported 4.99% stake indicates a meaningful but non-controlling position; voting and disposition are shared through the manager.
The filing discloses that Armistice Capital, via its Master Fund, holds 135,531 shares (4.99%). This is below the 5% beneficial-ownership threshold that often triggers heightened regulatory and market scrutiny, so the position does not, on its face, indicate a change in control. The filing clarifies voting and dispositive power are shared, not sole, and that the Master Fund retains economic rights to distributions. For investors, this is a transparency disclosure of an active investment manager holding a material minority stake without apparent control intent.
TL;DR: Disclosure shows coordinated filing by manager and managing member, with shared voting power and explicit non-control certification.
The joint Schedule 13G/A is signed by both Armistice Capital and Steven Boyd and includes a certification that the securities are held in the ordinary course of business and not to influence control. The statement that the Master Fund disclaims beneficial ownership in respect of voting/disposition due to the investment management agreement is a standard governance clarification. This filing documents ownership structure and responsibilities among reporting persons but does not report governance changes at the issuer.
Armistice Capital, LLC e Steven Boyd comunicano la titolarit脿 condivisa di 135.531 azioni ordinarie di Creative Medical Technology Holdings, Inc., pari al 4,99% della classe. Armistice Capital, in qualit脿 di gestore degli investimenti per Armistice Capital Master Fund Ltd., esercita il diritto di voto e il potere d'investimento sulle azioni detenute dal Master Fund; il sig. Boyd, in qualit脿 di membro amministratore, viene segnalato con gli stessi poteri congiunti di voto e disposizione. La comunicazione precisa che le azioni sono state acquisiste e sono detenute nell'ordinaria attivit脿 d'impresa e non con l'intento di modificare o influenzare il controllo dell'emittente. Il Master Fund 猫 indicato come detentore diretto e mantiene il diritto a ricevere dividendi o proventi di vendita.
Armistice Capital, LLC y Steven Boyd informan de la propiedad conjunta de 135.531 acciones ordinarias de Creative Medical Technology Holdings, Inc., que representan el 4,99% de la clase. Armistice Capital, como gestor de inversiones de Armistice Capital Master Fund Ltd., ejerce el derecho de voto y el poder de inversi贸n sobre las acciones en poder del Master Fund; el Sr. Boyd, como miembro gerente, figura con los mismos poderes compartidos de voto y disposici贸n. La presentaci贸n indica que las acciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no con la intenci贸n de cambiar o influir en el control del emisor. El Master Fund se identifica como el titular directo y conserva el derecho a recibir dividendos o los ingresos de una venta.
Armistice Capital, LLC鞕� Steven Boyd電� Creative Medical Technology Holdings, Inc. 氤错喌欤� 135,531欤茧ゼ 瓿惦彊鞙茧 鞁れ鞝侅溂搿� 靻岇湢頃橁碃 鞛堨溂氅� 鞚措姅 韥措灅鞀れ潣 4.99%鞐� 頃措嫻頃滊嫟瓿� 氤搓碃頃╇媹雼�. Armistice Capital鞚� Armistice Capital Master Fund Ltd.鞚� 韴瀽甏�毽瀽搿滌劀 毵堨姢韯� 韼�霌滉皜 氤挫湢頃� 欤检嫕鞐� 雽�頃� 鞚橁舶甓岅臣 韴瀽甓岇潉 頄夓偓頃橂┌, Boyd 鞌姅 甏�毽� 甑劚鞗愳溂搿滌劀 霃欖澕頃� 瓿惦彊 鞚橁舶甓� 氚� 觳橂秳甓岇潉 氤挫湢頃� 瓴冹溂搿� 氤搓碃霅╇媹雼�. 鞝滌稖靹滊電� 頃措嫻 欤检嫕鞚� 鞓侅梾鞚� 韱奠儊鞝� 瓿检爼鞐愳劀 旆摑路氤挫湢霅橃棃鞙茧┌ 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳範 氇╈爜鞙茧 氤挫湢霅� 瓴冹澊 鞎勲嫎鞚� 氇呾嫓頃╇媹雼�. 毵堨姢韯� 韼�霌滊姅 歆侅爲 氤挫湢鞛愲 頇曥澑霅橂┌ 氚半嫻旮� 霕愲姅 毵り皝 雽�旮堨潉 靾橂牴頃� 甓岆Μ毳� 鞙犾頃╇媹雼�.
Armistice Capital, LLC et Steven Boyd d茅clarent la propri茅t茅 b茅n茅ficiaire conjointe de 135听531 actions ordinaires de Creative Medical Technology Holdings, Inc., repr茅sentant 4,99聽% de la cat茅gorie. Armistice Capital, en tant que gestionnaire d'investissement pour Armistice Capital Master Fund Ltd., exerce les droits de vote et le pouvoir d'investissement sur les actions d茅tenues par le Master Fund ; M. Boyd, en tant que membre gestionnaire, est indiqu茅 comme d茅tenant les m锚mes pouvoirs conjoints de vote et de disposition. Le d茅p么t pr茅cise que les actions ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le de l'茅metteur. Le Master Fund est identifi茅 comme le d茅tenteur direct et conserve le droit de percevoir dividendes ou produits de cession.
Armistice Capital, LLC und Steven Boyd melden die gemeinsame wirtschaftliche Eigent眉merschaft an 135.531 Stammaktien der Creative Medical Technology Holdings, Inc., was 4,99 % der Klasse entspricht. Armistice Capital 眉bt als Investmentmanager des Armistice Capital Master Fund Ltd. Stimm- und Anlagebefugnisse 眉ber die vom Master Fund gehaltenen Aktien aus; Herr Boyd wird als gesch盲ftsf眉hrendes Mitglied mit denselben gemeinsamen Stimm- und Verf眉gungsbefugnissen angegeben. Die Meldung erkl盲rt, dass die Aktien im gew枚hnlichen Gesch盲ftsverlauf erworben und gehalten werden und nicht zum Zweck der 脛nderung oder Beeinflussung der Kontrolle des Emittenten dienen. Der Master Fund wird als direkter Inhaber genannt und beh盲lt das Recht, Dividenden oder Verkaufserl枚se zu erhalten.
FAQ
How many shares of CELZ does Armistice Capital report owning?
What percentage of CELZ does the reported holding represent?
Does the filing indicate Armistice Capital has sole voting or dispositive power?
Who is the direct holder of the reported shares?
Did the filing state the purpose of the investment?
